MiMedx Group, Inc.
MDXG
$3.56
$0.010.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -50.05% | 3.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -50.05% | 3.84% | |||
| Cost of Revenue | -8.85% | 1.79% | |||
| Gross Profit | -57.97% | 4.25% | |||
| SG&A Expenses | -27.15% | 5.90% | |||
| Depreciation & Amortization | 133.33% | 15.18% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.65% | 5.99% | |||
| Operating Income | -176.14% | -5.02% | |||
| Income Before Tax | -170.34% | -4.61% | |||
| Income Tax Expenses | -167.70% | 8.24% | |||
| Earnings from Continuing Operations | -171.49% | -9.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -171.49% | -9.30% | |||
| EBIT | -176.14% | -5.02% | |||
| EBITDA | -159.40% | -11.58% | |||
| EPS Basic | -171.35% | -9.28% | |||
| Normalized Basic EPS | -170.11% | -4.66% | |||
| EPS Diluted | -173.27% | -9.18% | |||
| Normalized Diluted EPS | -171.11% | -4.93% | |||
| Average Basic Shares Outstanding | 0.24% | 0.04% | |||
| Average Diluted Shares Outstanding | -1.16% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||